Literature DB >> 2031362

Recurrent pyogenic cholangitis: current management.

S T Fan1, T K Choi, J Wong.   

Abstract

Successful treatment of recurrent pyogenic cholangitis depends on the ability to delineate the pathology of the entire biliary system and to eradicate all stones, strictures, and destroyed liver segments. Recent advances in imaging techniques and stone fragmentation technology have been applied successfully in the management of this condition. Apart from direct cholangiography and ultrasonography, valuable information can be obtained from computed tomography which is particularly helpful in patients with recurrent disease after previous biliary surgery. Application of electrohydraulic lithotripsy in this disease solves the problem of difficult stone retrieval due to large size, impaction behind relative strictures and inside angulated segmental bile ducts. Together with construction of a hepaticocutaneous jejunostomy serving as a permanent access to the bile duct, it is anticipated that the incidence of recurrence and reoperation in the future can be reduced.

Entities:  

Mesh:

Year:  1991        PMID: 2031362     DOI: 10.1007/bf01659060

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  23 in total

1.  Emergency surgery for severe acute cholangitis. The high-risk patients.

Authors:  E C Lai; P C Tam; I A Paterson; M M Ng; S T Fan; T K Choi; J Wong
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

2.  Percutaneous transhepatic cholangioscopic ultrasonic lithotripsy (PTCS-USL) in the treatment of retained or recurrent intrahepatic stones.

Authors:  M H Hwang; L R Mo; J C Yang; C S Lin
Journal:  Gastrointest Endosc       Date:  1987-08       Impact factor: 9.427

3.  Partial hepatectomy for intrahepatic stones.

Authors:  T K Choi; J Wong
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

4.  Subcutaneous bling loop--a new type of hepaticocholedochojejunostomy for bilateral intrahepatic calculi.

Authors:  F Kan; C Tsung-chih
Journal:  Chin Med J (Engl)       Date:  1977-11       Impact factor: 2.628

5.  Pathogenesis of calcium bilirubinate gallstone: role of E. coli, beta-glucuronidase and coagulation by inorganic ions, polyelectrolytes and agitation.

Authors:  T Maki
Journal:  Ann Surg       Date:  1966-07       Impact factor: 12.969

6.  Postoperative flexible choledochoscopy for residual primary intrahepatic stones.

Authors:  T K Choi; M Fok; M J Lee; R Lui; J Wong
Journal:  Ann Surg       Date:  1986-03       Impact factor: 12.969

7.  Recurrent pyogenic cholangitis: a study by endoscopic retrograde cholangiography.

Authors:  S K Lam; K P Wong; P K Chan; H Ngan; G B Ong
Journal:  Gastroenterology       Date:  1978-06       Impact factor: 22.682

8.  Recurrent pyogenic cholangitis: ultrasound evaluation compared with endoscopic retrograde cholangiopancreatography.

Authors:  E M Chau; L L Leong; F L Chan
Journal:  Clin Radiol       Date:  1987-01       Impact factor: 2.350

9.  Intrahepatic lithiasis. Study of thirty-six cases and review of the literature.

Authors:  M Simi; P Loriga; A Basoli; S Leardi; V Speranza
Journal:  Am J Surg       Date:  1979-03       Impact factor: 2.565

10.  Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver.

Authors:  H Bismuth; M B Corlette
Journal:  Surg Gynecol Obstet       Date:  1975-02
View more
  3 in total

1.  Oriental cholangiohepatitis masquerading as cholangiocarcinoma: A rare presentation that surgeons need to know.

Authors:  Smit Singla; Anne H Warner; Ashokkumar Jain; Rebecca M Thomas; Andreas Karachristos
Journal:  Int J Surg Case Rep       Date:  2012-03-16

2.  Recurrent Pyogenic Cholangitis.

Authors:  D. Rohan Jeyarajah
Journal:  Curr Treat Options Gastroenterol       Date:  2004-04

3.  Recurrent pyogenic cholangitis: disease characteristics and patterns of recurrence.

Authors:  Ye Xin Koh; Adrian Kah Heng Chiow; Aik Yong Chok; Lip Seng Lee; Siong San Tan; Salleh Ibrahim
Journal:  ISRN Surg       Date:  2013-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.